Form 4 for NRXP NRX Pharmaceuticals, Inc.
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-03 · accession 0000880984-22-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-06-07 | 2022-06-03+ | NRXP | Javitt Daniel C. | 10% | S - Sale | $0.6825 | -445.7K | 12.86M | -3% | -$304.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-07 | S | D | 86,459 | $0.65 | 12,656,964 | I by Glytech LLC | — | — | (F1) Held by Glytech LLC of which the Reporting Person is the sole owner. |
| 2 | Common | Common Stock | 2022-06-06 | S | D | 115,657 | $0.67 | 12,743,423 | I by Glytech LLC | — | — | (F1) Held by Glytech LLC of which the Reporting Person is the sole owner. |
| 3 | Common | Common Stock | 2022-06-03 | S | D | 243,596 | $0.7 | 12,859,080 | I by Glytech LLC | — | — | (F1) Held by Glytech LLC of which the Reporting Person is the sole owner. |